Mycobacterium tuberculosis in children with human immunodeficiency virus type 1 infection

Y. F. Khouri, M. T. Mastrucci, C. Hutto, Charles D Mitchell, Gwendolyn B Scott

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

A retrospective study was conducted at the Childrens Hospital Center at Jackson Memorial Hospital in Miami, FL, to evaluate the natural history of Mycobacterium tuberculosis infection in nine children with vertically acquired human immunodeficiency virus type 1 infection. The patients' ages ranged from 6 months to 7 years (median age, 42 months). Common presenting symptoms included prolonged fever, cough and anorexia. Only one patient had a positive tuberculin test. Five patients evidenced only pulmonary disease, three patients had pulmonary and extrapulmonary disease and one patient developed extrapulmonary tuberculosis (mastoiditis) and pulmonary interstitial disease that could not be attributed to mycobacterial infection because of lack of information. Organisms isolated before January, 1989, were susceptible to isoniazid and rifampin whereas isolates from three patients cultured after that time were resistant to multiple antituberculosis drugs. The median survival time after M. tuberculosis diagnosis for all children was 20 months. Our study suggests that children with human immunodeficiency virus type 1 infection who have tuberculosis have an increased risk for extrapulmonary disease. A high index of suspicion for the diagnosis of M. tuberculosis should be maintained in human immunodeficiency virus type 1- infected children with prolonged fever and respiratory symptoms. In areas of high endemicity of multidrug-resistant organisms, therapy with a broader panel of drugs may need to be instituted until susceptibility testing becomes available.

Original languageEnglish
Pages (from-to)950-955
Number of pages6
JournalPediatric Infectious Disease Journal
Volume11
Issue number11
StatePublished - Jan 1 1992

Fingerprint

Virus Diseases
Mycobacterium tuberculosis
HIV-1
Lung Diseases
Tuberculosis
Fever
Mastoiditis
Tuberculin Test
Mycobacterium Infections
Isoniazid
Anorexia
Rifampin
Cough
Pharmaceutical Preparations
Retrospective Studies
Survival
Infection

Keywords

  • acquired immunodeficiency syndrome
  • children
  • human immunodeficiency virus
  • pediatrics
  • Tuberculosis

ASJC Scopus subject areas

  • Microbiology (medical)
  • Pediatrics, Perinatology, and Child Health

Cite this

Mycobacterium tuberculosis in children with human immunodeficiency virus type 1 infection. / Khouri, Y. F.; Mastrucci, M. T.; Hutto, C.; Mitchell, Charles D; Scott, Gwendolyn B.

In: Pediatric Infectious Disease Journal, Vol. 11, No. 11, 01.01.1992, p. 950-955.

Research output: Contribution to journalArticle

@article{400285b7f0c4477c8fe317664cbe37c1,
title = "Mycobacterium tuberculosis in children with human immunodeficiency virus type 1 infection",
abstract = "A retrospective study was conducted at the Childrens Hospital Center at Jackson Memorial Hospital in Miami, FL, to evaluate the natural history of Mycobacterium tuberculosis infection in nine children with vertically acquired human immunodeficiency virus type 1 infection. The patients' ages ranged from 6 months to 7 years (median age, 42 months). Common presenting symptoms included prolonged fever, cough and anorexia. Only one patient had a positive tuberculin test. Five patients evidenced only pulmonary disease, three patients had pulmonary and extrapulmonary disease and one patient developed extrapulmonary tuberculosis (mastoiditis) and pulmonary interstitial disease that could not be attributed to mycobacterial infection because of lack of information. Organisms isolated before January, 1989, were susceptible to isoniazid and rifampin whereas isolates from three patients cultured after that time were resistant to multiple antituberculosis drugs. The median survival time after M. tuberculosis diagnosis for all children was 20 months. Our study suggests that children with human immunodeficiency virus type 1 infection who have tuberculosis have an increased risk for extrapulmonary disease. A high index of suspicion for the diagnosis of M. tuberculosis should be maintained in human immunodeficiency virus type 1- infected children with prolonged fever and respiratory symptoms. In areas of high endemicity of multidrug-resistant organisms, therapy with a broader panel of drugs may need to be instituted until susceptibility testing becomes available.",
keywords = "acquired immunodeficiency syndrome, children, human immunodeficiency virus, pediatrics, Tuberculosis",
author = "Khouri, {Y. F.} and Mastrucci, {M. T.} and C. Hutto and Mitchell, {Charles D} and Scott, {Gwendolyn B}",
year = "1992",
month = "1",
day = "1",
language = "English",
volume = "11",
pages = "950--955",
journal = "Pediatric Infectious Disease Journal",
issn = "0891-3668",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - Mycobacterium tuberculosis in children with human immunodeficiency virus type 1 infection

AU - Khouri, Y. F.

AU - Mastrucci, M. T.

AU - Hutto, C.

AU - Mitchell, Charles D

AU - Scott, Gwendolyn B

PY - 1992/1/1

Y1 - 1992/1/1

N2 - A retrospective study was conducted at the Childrens Hospital Center at Jackson Memorial Hospital in Miami, FL, to evaluate the natural history of Mycobacterium tuberculosis infection in nine children with vertically acquired human immunodeficiency virus type 1 infection. The patients' ages ranged from 6 months to 7 years (median age, 42 months). Common presenting symptoms included prolonged fever, cough and anorexia. Only one patient had a positive tuberculin test. Five patients evidenced only pulmonary disease, three patients had pulmonary and extrapulmonary disease and one patient developed extrapulmonary tuberculosis (mastoiditis) and pulmonary interstitial disease that could not be attributed to mycobacterial infection because of lack of information. Organisms isolated before January, 1989, were susceptible to isoniazid and rifampin whereas isolates from three patients cultured after that time were resistant to multiple antituberculosis drugs. The median survival time after M. tuberculosis diagnosis for all children was 20 months. Our study suggests that children with human immunodeficiency virus type 1 infection who have tuberculosis have an increased risk for extrapulmonary disease. A high index of suspicion for the diagnosis of M. tuberculosis should be maintained in human immunodeficiency virus type 1- infected children with prolonged fever and respiratory symptoms. In areas of high endemicity of multidrug-resistant organisms, therapy with a broader panel of drugs may need to be instituted until susceptibility testing becomes available.

AB - A retrospective study was conducted at the Childrens Hospital Center at Jackson Memorial Hospital in Miami, FL, to evaluate the natural history of Mycobacterium tuberculosis infection in nine children with vertically acquired human immunodeficiency virus type 1 infection. The patients' ages ranged from 6 months to 7 years (median age, 42 months). Common presenting symptoms included prolonged fever, cough and anorexia. Only one patient had a positive tuberculin test. Five patients evidenced only pulmonary disease, three patients had pulmonary and extrapulmonary disease and one patient developed extrapulmonary tuberculosis (mastoiditis) and pulmonary interstitial disease that could not be attributed to mycobacterial infection because of lack of information. Organisms isolated before January, 1989, were susceptible to isoniazid and rifampin whereas isolates from three patients cultured after that time were resistant to multiple antituberculosis drugs. The median survival time after M. tuberculosis diagnosis for all children was 20 months. Our study suggests that children with human immunodeficiency virus type 1 infection who have tuberculosis have an increased risk for extrapulmonary disease. A high index of suspicion for the diagnosis of M. tuberculosis should be maintained in human immunodeficiency virus type 1- infected children with prolonged fever and respiratory symptoms. In areas of high endemicity of multidrug-resistant organisms, therapy with a broader panel of drugs may need to be instituted until susceptibility testing becomes available.

KW - acquired immunodeficiency syndrome

KW - children

KW - human immunodeficiency virus

KW - pediatrics

KW - Tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=0026441432&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026441432&partnerID=8YFLogxK

M3 - Article

VL - 11

SP - 950

EP - 955

JO - Pediatric Infectious Disease Journal

JF - Pediatric Infectious Disease Journal

SN - 0891-3668

IS - 11

ER -